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Cholesterol is a lipid that plays essential 
and diverse roles in biology. In verte-
brates, cholesterol can be synthesized 
through a series of enzymatic steps in 
the endoplasmic reticulum of a cell or 
can be taken up from the serum as cho-
lesterol esters stored in lipoprotein par-
ticles (Voet and Voet, 2011). Cellular 
cholesterol is predominately found in 
plasma membranes, where it serves as 
an important regulator of membrane 
fluidity and dynamics. Additional im-
portant functions include serving as the 
backbone of steroid hormone and bile 
acid synthesis, and lipid modification 
to proteins. Oxysterols are oxidized 
derivatives of cholesterol that are gen-
erated through the enzymatic actions 
of P450 cytochrome oxidases (e.g., 
CYP7b1) or via autoxidation (Russell, 
2000). Although oxysterols exist in very 
small quantities within the cell when 
compared with cholesterol, they have 
potent and pleiotropic biological ef-
fects. The best-defined example of the 
cross talk between oxysterols and innate 
immunity has been described in the 
pathogenesis of atherosclerosis and re-
lated cardiovascular disease pathogenesis, 
and we direct the reader to several ex-
cellent reviews on this subject (Bensinger 
and Tontonoz, 2008; Moore and Tabas, 
2011; Calkin and Tontonoz, 2012). 
Unexpectedly, several recent studies 
have identified oxysterols as critical 
signaling molecules in the development 
and function of the immune system 
(Bensinger et al., 2008; A-Gonzalez 
et al., 2009; Hannedouche et al., 2011; 
Liu et al., 2011; Hong et al., 2012; 
A-Gonzalez et al., 2013; Westerterp 
et al., 2013). In this issue, a new study 
by Raccosta et al. highlights how tumor-
derived oxysterols are potent signaling 
molecules co-opted by solid tumors to 
recruit protumorigenic neutrophils into 
the tumor microenvironment. These 
studies add to the growing list of how 
oxysterols modulate the immune sys-
tem and raise the intriguing possibility 
that targeting tumor-derived oxysterols 
could serve as a fresh approach to con-
trolling solid tumor growth.
The best understood function of 
oxysterol signaling is in the regulation 
of cellular cholesterol homeostasis. Cel-
lular cholesterol levels are largely main-
tained through the activity of two 
transcription factors, the sterol regula-
tory element binding proteins (SREBP1 
and SREBP2) and the liver X receptors 
(LXR and ; Horton et al., 2002; 
Bensinger and Tontonoz, 2008). If a cell 
has sufficient cholesterol, then SREBP 
proteins are held inactive in the endo-
plasmic reticulum via its association 
with two sterol-sensing proteins, INSIG 
and SCAP. Under conditions of low 
cellular cholesterol or specific oxysterols 
(e.g., 25-HC), SREBP proteins translo-
cate to the nucleus and transactivate the 
genes that encode the enzymes required 
for synthesis of cholesterol, as well as for 
proteins involved in low-density lipo-
protein uptake (e.g., LDL receptor; 
Horton et al., 2002). Conversely, when 
excess oxysterols (e.g., 22-(R) and 25-
hydroxycholesterol) accumulate in the 
cell, they can directly bind to and acti-
vate LXRs, resulting in transcriptional 
up-regulation of genes involved in cho-
lesterol efflux (Calkin and Tontonoz, 
2012). LXR proteins also attenuate in-
flammation in immune cells through 
their ability to directly repress inflam-
matory gene expression through a pro-
cess termed transrepression (Bensinger 
and Tontonoz, 2008). In combination, 
these two transcriptional programs reg-
ulate a cell’s cholesterol levels while also 
avoiding deleterious inflammation as-
sociated with excess lipid accumulation 
in tissues.
Oxysterols are oxidized derivatives of cholesterol that are generated enzy-
matically or through autoxidation. Initially identified as important lipid 
signaling molecules in the context of atherosclerosis and inflammation, 
accumulated evidence indicates that these lipid-signaling molecules can have 
pleiotropic effects on the fate and function of the immune system. These 
effects range from the regulation of immune cell survival and proliferation to 
chemotaxis and antiviral immunity. New studies now indicate that tumor-
derived oxysterols can serve to subvert the immune system by recruiting 
protumorigenic neutrophils into the tumor microenvironment. The conse-
quence of this recruitment is the generation of proangiogenic factors and 
matrix metalloproteinase proteins that provide a tumor a significant growth 
and survival advantage. In combination with other recent studies, these data 
highlight the ongoing cross talk between sterol metabolism and the immune 
system, and they raise the intriguing possibility that targeting oxysterol 
pathways could serve as a novel therapeutic approach in the war on cancer.
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(SULT2B1b) significantly attenuated 
neutrophil infiltrate and tumor growth.
Although one might expect that 
infiltration of neutrophils into tumors 
would favor a proinflammatory envi-
ronment and facilitate antitumor host 
immunity, it has become increasingly clear 
that in solid tumors, invading neutro-
phils (or other myeloid cells) provide an 
important growth and survival advantage 
for tumors (Motz and Coukos, 2011). 
Consistent with this concept, high lev-
els of tumor-infiltrating neutrophils and 
CXCR2 expression in tumor stroma 
are associated with poorer clinical out-
comes in some human cancers ( Jensen 
et al., 2009; Saintigny et al., 2013; Singh 
et al., 2013). The mechanisms underlying 
the protumorigenic function of tumor-
associated neutrophils are likely multi-
factorial, but the Raccosta et al. study 
suggests that it is reliant in part on the 
production of the proangiogenic factor 
BV8 and the release of matrix metallo-
proteinase MMP-9. Interestingly, the 
authors did not observe a significant sup-
pressive function of tumor-associated 
neutrophils on T cell populations, dis-
tinguishing their protumorigenic role 
from that of the immune modulatory 
activity attributed to many other infil-
trating myeloid cells, such as myeloid-
derived suppressor cells.
Finally, these findings shed light as 
to why tumors might produce such 
significant levels of oxysterols. These 
molecules can have significant antipro-
liferative effects, and it would seem that 
localized production of oxysterols would 
attenuate cancer cell cycle progression 
and survival. However, these data indi-
cate that the chemotactic signals of 
oxysterols may outweigh the antiprolif-
erative effects, and imply that inhibition 
of oxysterols could provide a novel ther-
apeutic target for both the generation of 
efficient antitumor immune responses 
and the inhibition of growth-promot-
ing myeloid tumor-infiltrating cells.
Like clockwork: oxysterols regulate 
innate immune cell homeostasis
Recent studies have also identified a 
prominent role for oxysterol signaling 
in the regulation of immune and he-
matopoietic cell homeostasis under 
oxysterols in facilitating host immunity, 
it is perhaps not surprising that tumors 
might subvert oxysterol pathways to 
dampen host antitumor immunity. In-
deed, studies have revealed a critical role 
for oxysterols in controlling the expres-
sion pattern of the chemokine (C-C 
motif) receptor 7 (CCR7) on tumor in-
filtrating DCs (Villablanca et al., 2010). 
Tumor-derived oxysterols were found 
to down-regulate the chemokine (C-C 
motif) receptor 7 (CCR7) in an LXR-
dependent manner. CCR7 is a member 
of the GPCR family, which was initially 
identified as a gene up-regulated in EBV 
infection, and plays a critical role in driv-
ing DC migration to draining lymph 
nodes. As such, suppression of CCR7 
would effectively trap DCs in the tumor, 
thereby interfering with antigen presen-
tation to antitumor T cells and host 
antitumor immunity. The mechanism 
of oxysterol-mediated CCR7 down-
regulation was dependent on activation 
of LXR in DCs. In light of the recent 
data showing that oxysterols act as che-
moattractants, it would be of interest to 
test oxysterols identified in tumor su-
pernatants for chemotactic ability on DCs 
independent of LXR signaling.
An additional layer of complexity is 
uncovered by new studies in this issue 
by Raccosta et al. (Fig. 1). Using mass 
spectrometry, they found that tumors 
produce an array of hydroxycholesterol 
species, in particular 22-HC and 27-HC, 
in sufficient quantities to activate LXR 
in tumor tissue as well as at distant tissues 
sites of the host, such as BM. Interest-
ingly, one functional consequence of 
oxysterol generation by cancer cells was 
a marked increase in the number of 
CD11bhighGr1high neutrophils infiltrating 
the tumor stroma (Fig. 1 A). Using a 
series of elegant approaches, including 
parabiosis of congenic hosts, they estab-
lish that oxysterols generated by tumor 
cells are necessary for the continuous re-
cruitment of neutrophils to the tumor 
site. This recruitment appeared to be de-
pendent on the binding of 22-HC oxy-
sterols to the GPCR CXCR2 and was 
independent of LXR activity. Impor-
tantly, inactivation of oxysterol genera-
tion by tumors via the ectopic expression 
of the cholesterol sulfotransferase 2B1b 
Oxysterols beckon cells
Although the LXR pathway plays an 
important role in regulating the cross 
talk between lipid metabolism and im-
munity, it is clear that not all oxysterols 
bind to and activate LXRs. Moreover, 
the addition of oxysterols to cultures 
can have pleiotropic effects on immune 
cells in an LXR-independent manner. 
Thus, it has been of considerable inter-
est to the field to unravel the molecular 
mechanisms by which oxysterols influ-
ence host immunity. A major advance in 
our understanding comes from recent 
exciting studies that demonstrated that 
oxysterols bind to and directly activate 
G protein–coupled receptors (GPCRs) 
on immune cells. The type I IFN induc-
ible oxysterol 7,25-OHC was identified 
as the ligand for the orphan receptor 
Epstein-Barr virus–induced gene 2 (Ebi2; 
Hannedouche et al., 2011; Liu et al., 
2011). This oxysterol, and other closely 
related oxysterol species, induce the 
migration of EBI2 receptor–positive B 
and T lymphocytes and DCs. The gen-
eration of the most potent oxysterol 
7,25-OHC appears to be dependent 
on two enzymes, 25-hydroxycholesterol 
7-hydroxylase (Cyp7b1) and cholesterol 
25-hydroxylase (Ch25h). LPS treatment 
of mice induced significant levels of 
7,25-OHC and migration of immune 
cells within the spleen in a Ch25h-de-
pendent manner. Intriguingly, Ch25h 
has long been associated with type I 
IFN responses, and recent work indi-
cates that one of the products of this 
enzyme, 25-hydroxycholesterol (25-HC), 
can have potent antiviral activity, al-
though the mechanism of action re-
mains poorly described (Blanc et al., 
2013; Liu et al., 2013). Nevertheless, these 
studies clearly demonstrate that multiple 
oxysterols are generated in the context 
of normal immune responses and their 
signals have important pleiotropic effects 
on host immunity.
Subverting oxysterols signaling  
to a tumors advantage
Tumors are expert at co-opting inflam-
matory pathways, and dampening host 
immunity to their growth and survival 
advantage (Hanahan and Weinberg, 2011). 
Given the emerging importance of 
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Moreover, activation of LXR by apop-
totic neutrophils in spleen repressed the 
expression of the granulopoietic cyto-
kines IL-23 and IL-17 (Hong et al., 
2012). How aged neutrophils find the 
appropriate resident tissue macrophages 
remains to be determined. Given the 
results of Raccosta et al. herein that 
oxysterols can drive neutrophil chemo-
taxis in a CXCR2-dependent manner, 
it would be of interest to determine if 
local production of oxysterols, such as 
22-HC, by tissue and BM macrophage 
serves as the elusive “find me” signals 
delivered to aged neutrophils.
Intriguing new studies have pro-
vided further insights into the intricate 
nature of cross talk between hemato-
poietic progenitor cells (HPCs), neutro-
phils, and the LXR signaling pathway 
(Casanova-Acebes et al., 2013; Fig. 1 B). 
Using elegant imaging techniques in 
combination with parabiosis, this study 
established that rhythmic oscillations of 
peripheral neutrophil and HPCs are in-
timately linked through the function of 
LXR. The authors found that senescent 
neutrophils home to the BM in a circa-
dian manner where they are presumably 
cleared by BM macrophage. The en-
gulfment of neutrophils by BM macro-
phage reduced the hematopoietic niche 
and resulted in the subsequent release of 
HPCs into the peripheral circulation. 
The genetic ablation of LXR resulted 
in the attenuation of the hematopoietic 
niche oscillations and rhythmic release 
of HPCs, suggesting that oxysterols play 
a fundamental role in controlling hema-
topoiesis. Collectively, these studies indi-
cate that that oxysterols play an important 
role in neutrophil biology.
LXR was also recently shown to be 
required for the differentiation of splenic 
marginal zone and metallophilic macro-
phage from hematopoietic precursors 
(A-Gonzalez et al., 2013). There is con-
siderable heterogeneity in splenic macro-
phage populations, and little is known 
regarding the transcriptional program 
that drives the differentiation of tissue 
macrophage from myeloid precursors. 
It remains unclear why oxysterols and 
LXR signaling would control the dif-
ferentiation of these specialized popu-
lations of macrophages. Nevertheless, 
mechanisms underlying the clearance 
of these cells by tissue macrophages re-
main poorly understood. Mice lacking 
both isoforms of LXR were found to 
have increased numbers of neutrophils 
in blood, spleen, and liver under non-
inflammatory conditions. In contrast, 
pharmacologic activation of the LXR 
pathway decreased circulating neutrophils 
in mice and increased aged neutrophil 
clearance by macrophages. Mechanistic 
studies revealed that engulfed apoptotic 
neutrophils activate LXR, resulting in 
the up-regulation of the c-mer proto- 
oncogene tyrosine kinase (MERTK), a key 
receptor in apoptotic cell phagocytosis. 
noninflammatory and nontumor con-
ditions. Building on studies that identi-
fied LXR as an important mediator 
apoptotic cell clearance by macrophages 
(A-Gonzalez et al., 2009), it was sug-
gested that LXR may play a physiologi-
cal role in the regulation of neutrophil 
homeostasis (Hong et al., 2012). Neutro-
phils are the most abundant cell type of 
the immune system with a short half-
life in healthy individuals, on the order 
of 3–12 h. Under noninflammatory con-
ditions, neutrophils are not activated, 
and the vast majority of these cells are 
cleared by resident tissue macrophages in 
the liver, spleen, and BM. The molecular 
Figure 1. An integral role for oxysterol in neutrophil fate and function. (A) Tumor-derived 
oxysterols facilitate tumor growth and survival. Some oxysterols inhibit tumor-associated DCs from 
migrating to lymphoid organs in an LXR-dependent manner, thereby promoting tumor evasion of the 
immune system. In addition, tumor-secreted oxysterols can act as a chemoattractant for proangio-
genic and protumorigenic CD11bhigh GR-1high neutrophils via the activation of GPCRs (e.g., CXCR2).  
(B) Aged neutrophils are phagocytized by BM macrophages in a circadian cycle. Phagocytosis activates 
LXR presumably by cholesterol and oxysterols in aged neutrophils. Activation of LXR restricts the size 
of the hematopoietic niche and inhibits mobilization of hematopoietic progenitor stem cells (HPSCs).
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studies discussed above, provide strong 
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the LXR axis plays a fundamental role 
in the control of hematopoietic cell fate 
and function.
A few final thoughts
Accumulating evidence indicates that 
oxysterols play an active and important 
role in the regulating the fate and function 
of immune cells. The study by Raccosta 
et al. presented herein demonstrates how 
this cross talk between lipid metabolism 
and the immune system can be subverted 
by tumors to promote their growth and 
survival. Although it is easy to hypothesize 
that oxysterols could serve as an important 
therapeutic target, it is important to realize 
that we are just beginning to understand 
how these lipid molecules impact in-
flammation, immunity, and hematopoi-
esis. Given the pleiotropic effect of these 
lipids, it will be necessary for the field to 
mechanistically determine when, where, 
and how these molecules are signaling. 
With this information in hand, it will 
become more apparent whether oxysterol 
pathways should be considered viable 
therapeutic targets.
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